Biotech · Private company · Brooklyn, NY, US
Lucerna, Inc.
Track this companyFree. Adds Lucerna, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- In vivo imaging platform for DM1 drug discoveryFiscal year 2025 · $313.1KNIH RePORTER 1R43AR086092-01 · fetched Nov 12, 2026
- Cell-based RNA degradation assay for C9ALS/FTD drug discoveryFiscal year 2024 · $392.1KNIH RePORTER 1R43AG085837-01 · fetched Nov 12, 2026
- Targeted RNA degradation assay for new antiviral drug discoveryFiscal year 2024 · $300KNIH RePORTER 1R43AI186768-01 · fetched Nov 12, 2026